Shuaiying Cui
Boston University(US)Boston Medical Center(US)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Epigenetics and DNA Methylation, Iron Metabolism and Disorders, RNA modifications and cancer, Prenatal Screening and Diagnostics
Most-Cited Works
- → Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction(2013)166 cited
- → Invertebrate Trehalose-6-Phosphate Synthase Gene: Genetic Architecture, Biochemistry, Physiological Function, and Potential Applications(2018)131 cited
- → Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease(2010)119 cited
- → Nuclear Receptors TR2 and TR4 Recruit Multiple Epigenetic Transcriptional Corepressors That Associate Specifically with the Embryonic β-Type Globin Promoters in Differentiated Adult Erythroid Cells(2011)110 cited
- → The role and possible mechanism of lncRNA U90926 in modulating 3T3-L1 preadipocyte differentiation(2016)92 cited
- → The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice(2015)89 cited
- → Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease(2017)87 cited
- → The LSD1 inhibitor RN-1 recapitulates the fetal pattern of hemoglobin synthesis in baboons (P. anubis)(2016)54 cited
- → Developmental transcriptome analysis of human erythropoiesis(2014)51 cited
- → A long noncoding RNA from the HBS1L-MYB intergenic region on chr6q23 regulates human fetal hemoglobin expression(2017)46 cited